The past 10 years saw a growth in nanotechnology-based agents used in various biological and medical areas, particularly molecular imaging, writes Andrew Tsourkas, a bioengineering professor from the University of Pennsylvania. As nanoparticles become increasingly adopted as molecular imaging probes, there is a need to develop methods that can be used to compare the agents, as well as targeting procedures to improve disease diagnosis, Tsourkas writes.

Full Story:

Related Summaries